Two advances in the management of Parkinson disease

Article Type
Changed
Thu, 12/13/2018 - 15:26
Display Headline
Two advances in the management of Parkinson disease
Article PDF
Author and Disclosure Information

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 69(8)
Publications
Topics
Page Number
639-643
Sections
Author and Disclosure Information

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Page Number
639-643
Page Number
639-643
Publications
Publications
Topics
Article Type
Display Headline
Two advances in the management of Parkinson disease
Display Headline
Two advances in the management of Parkinson disease
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media